96 related articles for article (PubMed ID: 2425939)
1. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
Marsh W; Sicheri D; Center MS
Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells.
Marsh W; Center MS
Cancer Res; 1987 Oct; 47(19):5080-6. PubMed ID: 3621192
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
Bhalla K; Hindenburg A; Taub RN; Grant S
Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug.
McGrath T; Center MS
Cancer Res; 1988 Jul; 48(14):3959-63. PubMed ID: 2898287
[TBL] [Abstract][Full Text] [Related]
5. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
Marquardt D; Center MS
Cancer Res; 1992 Jun; 52(11):3157-63. PubMed ID: 1591727
[TBL] [Abstract][Full Text] [Related]
6. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells.
Aquino A; Hartman KD; Knode MC; Grant S; Huang KP; Niu CH; Glazer RI
Cancer Res; 1988 Jun; 48(12):3324-9. PubMed ID: 3130982
[TBL] [Abstract][Full Text] [Related]
7. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
Inaba M; Kobayashi H; Sakurai Y; Johnson RK
Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
[TBL] [Abstract][Full Text] [Related]
8. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
Burres NS; Myers MT; Sartorelli AC
Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
10. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
Harker WG; Sikic BI
Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002
[TBL] [Abstract][Full Text] [Related]
11. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
Beck WT; Cirtain MC; Lefko JL
Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
[TBL] [Abstract][Full Text] [Related]
12. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
[TBL] [Abstract][Full Text] [Related]
13. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
14. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
15. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the involvement of two distinct membrane proteins in adriamycin resistance in Chinese hamster lung cells.
Marsh W; Center MS
Cancer Res; 1985 Dec; 45(12 Pt 1):6088-92. PubMed ID: 4063966
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of membrane protein changes in multidrug resistant HL-60 cells.
Krishnamachary N; Center MS
Oncol Res; 1992; 4(1):23-8. PubMed ID: 1581617
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants.
Tapiero H; Munck JN; Fourcade A; Lampidis TJ
Cancer Res; 1984 Dec; 44(12 Pt 1):5544-9. PubMed ID: 6498816
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
Bhalla K; Nayak R; Grant S
Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
